Linge J, Cariou B, Neeland IJ, Petersson M, Rodríguez Á, Leinhard OD, (2023), Skewness in body fat distribution pattern links to specific cardiometabolic disease risk profiles, JCEM, https://doi.org/10.1210/clinem/dgad570
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Sanyal.J A, Kaplan M Lee, Frias P J, Brouwers B, Wu O, Thomas K M, Harris C, Schloot C N, Du Y, Mather J K, Haupt A, Hartman L M, (2024) Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial, Nature Medicine, https://doi.org/10.1038/s41591-024-03018-2
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial
Tawil R, Wagner R K, Hamel I J, Leung G D, Statland M J, Wang H L, Genge A, Sacconi S, Lochmüller H, Reyes-Leiva D, Diaz-Manera J, Alonso-Perez J, Muelas N, Vilchez J J, Pestronk A, Gibson S, Goyal A N, Hayward J L, Johnson N, LoRusso S, Freimer M, Shieh B P, Subramony H S, van Engelen B, Kools J, Leinhard D O, Widholm P, Morabito C, Moxham M C, Cadavid D, Mellion L M, Odueyungbo A, Tracewell G W, Accorsi A, Ronco L, Gould J R, Shoskes J, Rojas L A, Jiang G J, (2024) Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial, The Lancet Neurology, https://doi.org/10.1016/S1474-4422(24)00073-5
Dissecting unique and common variance across body and brain health indicators using age prediction
Beck D, de Lange G A-M, Gurholt P T, Voldsbekk I, Maximov I I, Subramaniapillai S, Schindler L, Hindley G, Leonardsen H E, Rahman Z, van der Meer D, Korbmacher M, Linge J, Leinhard D O, Kalleberg T K, Engvig A, Sønderby I, Andreassen A O, Westlye T L, (2024) Dissecting unique and common variance across body and brain health indicators using age prediction, Human Brain Mapping, https://doi.org/10.1002/hbm.26685
Body composition and body fat distribution in tissue-specific insulin resistance and in response to a 12-week isocaloric dietary macronutrient intervention
Trouwborst I, Jardon KM, Gijbels A, Hul G, Feskens J.M E, Afman A L, Linge J, Goossens H G, E. Blaak E, (2024), Body composition and body fat distribution in tissue-specific insulin resistance and in response to a 12-week isocaloric dietary macronutrient intervention, (2024), BMC Nutrition & Metabolism, https://doi.org/10.1186/s12986-024-00795-y
(CorMorMent) Linking Sarcopenia, Brain Structure, and Cognitive Performance: A large-scale UK Biobank study
Gurholt P T, Germán Borda M, Parker N, Fominykh V, Kjelkenes R, Linge J, van der Meer D, Sønderby E I, Duque G, Westlye T L, Aarsland D, Andreassen A O, (2024), (CorMorMent) Linking Sarcopenia, Brain Structure, and Cognitive Performance: A large-scale UK Biobank study, Oxford Academic, https://doi.org/10.1093/braincomms/fcae083